Dr Yusuf Hamied, pharmaceutical chemist and Chairman of Cipla Limited received an Honorary Doctorate from the University on 18 June 2014. Dr Hamied is an Honorary Fellow of Christ's College, a member of the Vice-Chancellor’s Circle of Advisors for India and a recipient of the Padma Bhushan.
For the first time the Department of Materials Science & Metallurgy has a single purpose-designed home, ensuring that Cambridge continues to be one of the world’s leading centres for materials science.
The Cancer Research UK Cambridge Research Institute is a unique partnership between the University of Cambridge and Cancer Research UK. It is dedicated to state-of-the-art research into the causes of cancer, and developing new treatments and bringing them to the clinic to benefit cancer patients.
“History remembers the thinkers, the people who have had a major impact on the way we perceive the world culturally or scientifically,” says George Efstathiou, 1909 Professor of Astrophysics and Director of the Kavli Institute for Cosmology.
A partnership led by the Medical Research Council (MRC) has awarded the University of Cambridge £25 million to provide cutting-edge equipment and infrastructure for its clinical research, from imaging single disease cells through to improved targeting of treatments for patients.
Research by a digital anthropologist is looking at how new religious movements are harnessing online platforms. These ‘invented religions’ take inspiration from ancient philosophy and recent cultural events to develop doctrine and communities of believers in digital spaces.
DefiniGEN is one of the first commercial opportunities to arise from Cambridge’s expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic cells for drug screening.